Impact (REF3a/b)
1 - Clinical Medicine
University of Cambridge
Impact template (REF3a)
Download template (198K)
All impact case studies
Download all case studies (2.4MB)
Individual case studies
Accelerating structural biology with Phaser crystallographic software-Read (141K)
Caesarean section and the risk of perinatal death- Gordon Smith (95K)
Coleman (94K)
Defining first line therapy for high risk essential thrombocythemia-Green (103K)
Development of Campath antibody as a therapeutic-Clark & Waldmann (115K)
Establishing an evidence-based therapeutic approach to ANCA-associated vasculitis-Jayne (105K)
Evidence based imaging – Impact of Body CT and MRI in clinical practice-Dixon (150K)
Genetic diagnosis and therapeutic intervention in patients with severe early onset obesity-o'Rahilly (118K)
Genetic risk assessment for age-related macular degeneration-Yates (207K)
Improved matching of therapeutic platelet concentrates for cancer patients and neonates- Ouewhand (104K)
Increasing access to kidney transplantation-Bradley (105K)
Meeting the diagnostic needs in resource-limited settings (354K)
Molecular markers for diagnosis of myeloproliferative neoplasms-Green (113K)
PREDICT: A prognostication and treatment benefit tool for early breast cancer - Caldas (111K)
Safer antibiotic therapy in cystic fibrosis patients-Floto (53K)
The AB/CD of treating hypertension-Brown (125K)